行情

ACHV

ACHV

Achieve
NASDAQ

实时行情|Nasdaq Last Sale

0.8574
-0.0226
-2.57%
盘后: 0.8800 +0.0226 +2.64% 19:59 12/11 EST
开盘
0.8900
昨收
0.8800
最高
0.8900
最低
0.8300
成交量
39.63万
成交额
--
52周最高
4.630
52周最低
0.8300
市值
716.17万
市盈率(TTM)
-0.3604
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ACHV 新闻

  • The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
  • Benzinga.16小时前
  • AUPH, DBI, FRAN and NLTX among midday movers
  • Seeking Alpha - Article.1天前
  • Achieve +22% premarket after FDA meeting on cytisinicline development program
  • seekingalpha.2天前
  • Achieve Life Sciences Announces Completion of Meeting with FDA on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
  • Benzinga.2天前

更多

所属板块

生物技术和医学研究
-0.34%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

ACHV 简况

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand.
展开

Webull提供Achieve Life Sciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。